Inflammatory arthritis a common rheumatic adverse event with ICIsOctober 17, 2018Rheumatoid ArthritisLupus & Connective Tissue Diseases
Anxiety and depression widespread among arthritis patientsOctober 8, 2018Rheumatoid ArthritisOsteoarthritisBusiness of Medicine
Sulfasalazine pinpointed as reason for high triple-therapy discontinuationSeptember 27, 2018Rheumatoid Arthritis
Pregnancy registries are a valuable resourceSeptember 21, 2018Ankylosing spondylitisLupus & Connective Tissue DiseasesOsteoporosisPainPsoriatic ArthritisRheumatoid Arthritis
Arthritis prevalent in older adults with any degree of depressionSeptember 21, 2018PainOsteoarthritisRheumatoid ArthritisSpondyloarthropathies
New insight into celiac disease: What you should knowSeptember 19, 2018Mixed TopicsLupus & Connective Tissue DiseasesRheumatoid Arthritis
Predictors for worse outcomes in low–disease activity RA remain tough to come bySeptember 17, 2018Rheumatoid Arthritis
Infliximab biosimilar only moderately less expensive in Medicare Part DSeptember 6, 2018Psoriatic ArthritisRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitis
Diclofenac’s cardiovascular risk confirmed in novel Nordic studySeptember 4, 2018PainRheumatoid ArthritisOsteoarthritisAnkylosing spondylitisSpondyloarthropathies
Noninferiority endpoint not met between Xeljanz formulations for RAAugust 21, 2018Rheumatoid Arthritis
